FLAG with Bortezomib in Childhood Relapsed Refractory Leukaemia- A
Single Centre Experience
Sreedhar Jayakrishnan, MD1*, Kesavan MR, MD, FNB
(Paediatric Hemato Oncology) 2, Gangadharan KV MD,
DM(Medical Oncology). 1, Sreelesh KP MD, DM (Medical
Oncology)1, Arun Chandrashekaran MD, DM (Medical
Oncology) 1, Sudeep Vaniyath MD, DM (Clinical
Haematology) 3, Karthika KV MD, DM (Hematopathology)4,
1 Department of Medical Oncology, ASTER MIMS,
Kozhikode, India
2 Department of Pediatric Hematology and
Hemato-Oncology, ASTER MIMS, Kozhikode, India
3 Department of Hematology and Hemato-Oncology, ASTER
MIMS, Kozhikode, India
4 Department of Pathology, ASTER MIMS, Kozhikode,
India
* Correspondence to:
Sreedhar Jayakrishnan, MD, Department of Medical Oncology, ASTER MIMS,
Kozhikode, Kerala, India , 673016
Tel.: +91-8495819063, Email:
srj1216353@gmail.com
Running Title- FLAG-Bortezomib in Paediatric relapsed/refractory
Leukaemia
Number of Tables- One
Key Words- Haematology, Haemato- Oncology, Relapsed Leukaemia, Toxicity,
Hematopoietic Stem Cell Transplant
Word Count-
1280 Words (Main Text)
106 (Abstract)